Cargando…
Coagulation profile of human COVID-19 convalescent plasma
Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the impact of pro-coagulant factors in convalescent plasma on the coagulation cascade particularly among patients with severe COVID-19. The aim of this study was to evaluate the coagulation profile of COVID-19 conval...
Autores principales: | Klompas, Allan M., van Helmond, Noud, Juskewitch, Justin E., Pruthi, Rajiv K., Sexton, Matthew A., Soto, Juan C. Diaz, Klassen, Stephen A., Senese, Katherine A., van Buskirk, Camille M., Winters, Jeffrey L., Stubbs, James R., Hammel, Scott A., Joyner, Michael J., Senefeld, Jonathon W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755772/ https://www.ncbi.nlm.nih.gov/pubmed/35022488 http://dx.doi.org/10.1038/s41598-021-04670-1 |
Ejemplares similares
-
In Reply — Micro-Thrombosis, Perfusion Defects, and Worsening Oxygenation in COVID-19 Patients: A Word of Caution on the Use of Convalescent Plasma
por: Klompas, Allan M., et al.
Publicado: (2021) -
In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021) -
Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19
por: Ripoll, Juan G., et al.
Publicado: (2021) -
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
por: Klassen, Stephen A., et al.
Publicado: (2021) -
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
por: Ripoll, Juan G., et al.
Publicado: (2022)